Key statistics
As of last trade VERTEX PHARMDRN (VRTX34:SAO) traded at 655.56, -12.41% below its 52-week high of 748.45, set on Nov 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 655.56 |
---|---|
High | 655.56 |
Low | 655.56 |
Bid | 648.70 |
Offer | 656.69 |
Previous close | 655.56 |
Average volume | 41.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Nov 22 2024 13:20 GMT.
More ▼
Press releases
- Vertex Reports Third Quarter 2024 Financial Results
- Vertex to Participate in Upcoming November Investor Conferences
- Vertex Provides Updates on Multiple Kidney Programs at the American Society of Nephrology (ASN) Annual Kidney Week Congress
- Vertex to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class, Highly Selective Pain Signal Inhibitor at the American Society of Anesthesiologists Annual Meeting
- Vertex to Announce Third Quarter 2024 Financial Results on November 4th
- Vertex Highlights First Oral Presentation of Phase 3 Clinical Data of the Vanza Triple and New Data on Long-Term Impact of TRIKAFTA® at the North American Cystic Fibrosis Conference
More ▼